Sartorius Aktiengesellschaft (SUVPF) Stock Price, News & Analysis

Company Overview

Sartorius Aktiengesellschaft is a global provider of laboratory and bioprocess technologies serving the biopharmaceutical, pharmaceutical and research sectors. The company’s core operations are organized into two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions offers single‐use bioreactors, filtration systems, chromatography media and cell culture media for the development and manufacture of monoclonal antibodies, vaccines and cell and gene therapies. Lab Products & Services provides laboratory instruments and consumables such as precision balances, pipetting devices, water purification systems and software solutions that support life science research and quality control.

Founded in 1870 by Florenz Sartorius in Göttingen, Germany, Sartorius began as a manufacturer of precision weighing equipment. Over the course of more than 150 years, the company has expanded its capabilities beyond laboratory balances into advanced analytical, separation and cell‐analysis technologies. Growth has been driven both organically and through strategic acquisitions, allowing Sartorius to broaden its portfolio in filtration, cell handling and single‐use components for bioprocessing applications.

Sartorius operates production sites, research and development centers, and sales offices across Europe, the Americas and the Asia-Pacific region, serving research institutions, contract development and manufacturing organizations (CDMOs), and pharmaceutical and biotech firms. Under the leadership of CEO Dr. Joachim Kreuzburg, the company employs over 10,000 people worldwide, with a focus on innovation, quality and sustainability in laboratory and bioprocess workflows.

Key Stats

• Today's Range: $259.02 to $259.02
• 50-Day Range: $256.81 to $263.10
• 52-Week Range: $198.85 to $289.33
• Volume: 13 shs
• Average Volume: 86 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SUVPF Stock Analysis - Frequently Asked Questions

How have SUVPF shares performed this year?

Sartorius Aktiengesellschaft's stock was trading at $219.8356 at the beginning of 2025. Since then, SUVPF stock has increased by 17.8% and is now trading at $259.02.

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SUVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/19/2025
• Next Earnings (Estimated): 7/22/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SUVPF
• CIK: N/A
• Web: www.sartorius.com
• Phone: 495513080
• Fax: N/A
• Employees: 14,614
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A